TherapeuticsMD Inc (TXMD): I would think Phase 3 trials are going w...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	75
Posts	8164
Boards Moderated	0
Alias Born	06/13/2013

JJ24

Re: JCB5 post# 137

Thursday, 03/03/2016 10:19:17 AM

Thursday, March 03, 2016 10:19:17 AM

I would think Phase 3 trials are going well if they want to present them at the conference . Monday could be a very big day here.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TXMD News

TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:22:58 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:20:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 09:18:30 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:59 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:15:28 AM
TherapeuticsMD Announces Second Quarter 2023 Financial Results • Business Wire • 08/14/2023 10:50:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:29:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:28:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2023 09:27:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 08:38:59 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/30/2023 12:29:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:21:32 PM
TherapeuticsMD Announces First Quarter 2023 Financial Results • Business Wire • 05/15/2023 08:05:00 PM

More TXMD News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover